Interferon-tau (IFNz) is produced by the trophectoderm of ruminant ungulates and its gene transactivation in vitro has so far been achieved only in human choriocarcinoma cells, JAR and JEG3. To examine if ovine
INTERFERON-v (IFNz) is a major peptide produced by the trophectoderm of pen-implantation conceptuses in ruminant ungulates [1] . Unlike IFNa, j9 or r, IFNz is not induced by viruses or double stranded RNA even though it possesses a strong antiviral activity [2, 3] . More importantly, IFN a, 3 or r is produced for only a few hours after viral stimulation, but IFNz production is maintained for 5 or more days. In addition, IFNz has an antiproliferative effect as other IFNs [4, 5] .
In order to understand the transcriptional regulation of IFNz gene, several experiments have been Received carried out, but, because of a lack of ruminant trophoblast cell lines, human choriocarcinoma cells, JAR or JEG3, are typically used [6] [7] [8] . Cross and Roberts (1991) show that IFNz gene expression is observed when human choriocarinoma cells, JAR, are transfected with the IFNz-reporter plasmid, but it is not seen when transfected into non-trophoblast GBK-2 or CHO cells [6] . It has been observed that production of IFNz by the ovine trophectoderm in vitro can be enhanced by the addition of GM-CSF or IL-3 [9, l0]. GM-CSF and IL-3, both proteins and mRNAs, are localized at luminal and glandular epithelia of the maternal endometrium.
The effect of these cytokines in the in vitro culture system is mimicked by the addition of a protein kinase C In this study, therefore, we examined the effect of PMA on ovine IFNz-reporter, chloramphenicol acetyltransferase (IFNz-CAT) transactivation in several cell lines in order to identify a cell line(s) which could support IFNz-CAT activation. We then investigated the effect of transcription factor expression on IFNz-CAT transactivation in co-transfection studies: Factors studied include c-Jun, c-Fos and c-Myc, all of which are activated by PMA [13] . Furthermore, we investigated IRF-1 and 2, which are involved in transcriptional regulation of IFNa and 3 genes, for their role in the transcriptional activation of IFNz-CAT. Materials and Methods
DNA constructs
The DNA sequence representing -654 to + 51 bases of ovine IFNzo10 gene [14] was inserted into the pCAT basic vector (IFNz-CAT). A human ~-actin promoter-CAT construct (j3-actin-CAT) that is expressed at high levels in a wide range of cell types [11] was used as a positive control. Expression of murine c-jun and c-fos is driven by the Rous Sarcoma Virus (RSV) LTR [15] . Chicken j3-actin promoter is used for the expression of murine IRF-1 and IRF-2, in pAct-1 and pAct-2 plasmid vectors, respectively. The c-myc expression plasmid is controlled by SV40 promoter/enhancer. pRVSV, which only contains RSV LTR and a poly (A) signal, was used as a control for the determination of basal transcriptional activity.
Cell culture and transient transfection
Cells used in all expriments, JEG3 (human choriocarcinoma cell; HTB36, American Type Culture Collection), 293 (human embryonic kidney cell; CCL81, American Type Culture Collection), HeLa (human cervical cancer cell; RCB0007, RIKEN Cell Bank) and Vero (African green monkey kidney cell; CRL 1573, American Type Culture Collection), were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS), 40 unit/ml of penicillin and 40 pg/ml of streptomycin.
IFNz-CAT constructs were transfected into cells by using TransFastTM (Promega). Transfection was performed according to the manufacturer's protocol. For co-transcription studies, 1 pg each of expression vector or pRVSV control vector along with 3 pg of IFNz-CAT were co-transfected as aforementioned. When a combination of c-jun and c-fos was examined, 0.5 pg each of c-jun and c-fos expression plasmids were used, which resulted in the same proportion of expression vectors to IFNz-CAT construct.
CA T assay
At 43-48 hour after transfection, the transfected cells were collected, and their extracts were used for CAT assay. CAT activity was assayed by the solvent partition method as previously described [16] and CAT activity was expressed as net dpm after the value of CAT vector without the promoter being subtracted from that of IFNz-CAT.
Transactivation of IFNz-CAT by PMA in each cell line was expressed as the ratio of the net dpm of 14C-product formed per hour for the positive control, 3-actin-CAT.
In cotransfection studies, IFNz-CAT activation was expressed as relative increase vs. pRVSV control vector.
Statistical analysis
The results Responsiveness of IFNz-CAT to PMA treatment in several cell lines, JEG3, 293, HeLa and Vero cells, is shown in Fig. 1 . In each cell line, jl-actin-CAT was used as a positive control, and the results, degrees of IFNz-CAT tansactivation, were expressed as percentage of the positive control. JEG3 transfected with IFNz-CAT responded to PMA positively and the CAT activities were 5.9 ± 0.6% and 44.8 ± 3.5% at 10 and 50 nM PMA, respectively. These observations were in agreement with the results described previously in which effective doses of PMA on IFNz-CAT activity were determined [11] . Surprisingly, higher CAT activities, 100.3 ± 5.0% and 106.3 ±4.6%, were observed in 293 cells when they were treated with PMA at 10 and 50 nM, respectively. However, in HeLa or Vero cells transcriptional 
Effects of several transcriptional factors
To examine the responsiveness of IFNz gene to various transcription factors, IFNz-CAT was cotransfected with each transcription factor expression vector or pRVSV ( Fig. 2A and 2B) . Two cell lines, JEG3 and HeLa that differed in the responsiveness of IFNz-CAT to PMA treatment, were examined. When JEG3 or HeLa cells were co-transfected with IFNz-CAT and c-jun expression plasmid, CAT activity was enhanced remarkably (JEG3 8.8 ± 1.3, HeLa 12.0± 1.5 fold activation), but c-fos vector alone was not as effective in IFNz gene transactivation as c-jun. The degree of transcriptional activation by a combination of c-jun and c-fos vectors was similar to that of c-jun plasmid alone. In addition, degrees of transcriptional activation achieved by cjun, c-fos and c-jun plus c-fos, respectively, were similar in HeLa and JEG3 cells. Furthermore, CAT activity was not affected by c-myc or IRF-1, and only modest enhancement was seen when IRF-2 was cotransfected with IFNz-CAT (JEG3 2.2±0.3, Hela 3.9±0.6 fold activation).
Discussion
It has been demonstrated that IFNz production by the ovine trophectoderm in vitro is enhanced by GM-CSF or PMA and that these effects are also observed when JAR or JEG3 cells are transiently transfected with the IFNz-CAT construct [9-11]. These lines of evidence suggest that JAR or JEG3 cells contain sufficient transcription factors to support IFNz expression. In addition, one or more of these factors seem to be activated by PMA.
In the present investigation, differences in transcriptional activity among several cell lines were observed (Fig.  1) , which might be due to differences in enhancer /silencer proteins existing in these cell lines. (Fig. 2) , but IFNz-CAT activation by c-fos expression was not as effective as c-jun or c-jun plus c-fos. In addition, no synergistic effect of c-jun and c-fos was observed. If IFNz-CAT activation was induced solely by c-jun homodimer, then CAT activity with c-jun/c-fos (0.5 ig each) treatment should be less than that of treatment with c-jun only in which one tig of the expression plasmid was co-transfected. c-jun/c-fos heterodimer may therefore have activated IFNz-CAT in the co-transfection study. Furthermore, although AP-l was originally identified in HeLa nuclear extract, the IFNz-CAT construct in HeLa cells was not activated by PMA treatment. This could be because a different set of nuclear proteins may have been activated by PMA, which in turn regulates IFNz gene transactivation in a negative manner.
IRF-1 was originally identified as a nuclear factor controlling transcriptional activation of IFNa and j3 genes. It was also found to control some other genes that are regulated by activated IFNa or 3 genes [22] . IRF-2 binds to the same element as IRF-1, but it represses IFNa, j9 and other genes of which trans-criptional activation is regulated by IRF-1 [23]. Our results indicate that IRF-1 does not seem to affect IFNz-CAT transactivation, which is in agreement with a previous report [7] . However, the expression of IRF-2 slightly enhanced the CAT activity and this observation could be supported by the fact that IRF-2 expression is associated with high levels of cell proliferation.
These results suggest that IRF-2, not IRF-1, may be associated with IFNz production in vivo since IFNz expression in significant quantity seems to coincide with the degree of conceptus elongation.
IFNz is produced only by the trophectoderm of ruminant ungulates. 
